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The authors of this paper [1] contacted the Journal on 
1 May 2020, shortly after its publication on 25 April 2020, 
and requested that it be retracted because of the 
following reasons:
-  the authors did not have permission from the dialysis
provider company to publish the data
-  some data were from different time frames and the
related results are therefore inaccurate
- consent was not obtained from all patients
-  some co-authors who should have been included, 
were not.
The editors of the Journal, after consultation with senior 
members of the editorial board, have decided that the 
article be retracted and that the relevant institutions and 
ethics committee be informed.
The metadata of the article has been amended to 
indicate the retraction and the PDF version of the paper, 
which will remain on the Journal website, now has a 
watermark indicating “RETRACTED”.
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